Rubusoside

CAS No. 64849-39-4

Rubusoside( UNII-TCV5K3M3GX )

Catalog No. M18952 CAS No. 64849-39-4

Rubusoside is a solubilizing agent with antiangiogenic and antiallergic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 71 In Stock
5MG 49 In Stock
10MG 81 In Stock
25MG 136 In Stock
50MG 202 In Stock
100MG 276 In Stock
200MG Get Quote In Stock
500MG 684 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rubusoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Rubusoside is a solubilizing agent with antiangiogenic and antiallergic properties.
  • Description
    Rubusoside is a natural sweetener.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UNII-TCV5K3M3GX
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    64849-39-4
  • Formula Weight
    642.73
  • Molecular Formula
    C32H50O13
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 32 mg/mL; 49.79 mM
  • SMILES
    CC12CCCC(C1CCC34C2CCC(C3)(C(=C)C4)OC5C(C(C(C(O5)CO)O)O)O)(C)C(=O)OC6C(C(C(C(O6)CO)O)O)O
  • Chemical Name
    Kaur-16-en-18-oic acid, 13-(beta-D-glucopyranosyloxy)-, beta-D-glucopyranosyl ester, (4alpha)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cimifugin beta-D-glu...

    Prim-O-glucosylcimifugin can inhibit the proliferation of SMC(smooth muscle cell) stimulated by TNF-alpha, increase the proportion of G0/G1 phase.

  • 8-Bromoguanosine

    8-Bromoguanosine is a brominated derivative of guanosine. It is activate lymphocytes through an intracellular mechanism to exert immunostimulatory effects.

  • Lasmiditan

    Lasmiditan, also known as COL-144 and LY573144, is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist (K1=2.21 μM) without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study.